Table 1 Estimates of analytic sensitivity for the four schemes included in the biochemical genetic laboratories proficiency testing program stratified by laboratory location

From: CAP/ACMG proficiency testing for biochemical genetics laboratories: a summary of performance

Scheme

Location

Analytic true positive a

Analytic false negative b

P value c

Amino acids

US

95.1% (1,122/1,180)

(93.9–96.3%)

4.9% (58/1,180)

(3.7–6.1%)

<0.001

 

International

89.4% (430/481)

(86.7–92.2%)

10.6% (51/481)

(7.9–13.3%)

 

Organic acids

US

93.5% (942/1,007)

(92.0–95.1%)

6.5% (65/1,007)

(4.9–8.0%)

0.043

 

International

90.4% (369/408)

(87.6–93.3%)

9.6% (39/408)

(6.7–12.4%)

 

Acylcarnitine profile

US

93.1% (471/506)

(90.9–95.3%)

6.9% (35/506)

(4.7–9.1%)

0.060

 

International

88.9% (192/216)

(84.7–93.1%)

11.1% (24/216)

(6.9–15.3%)

 

Mucopolysaccharides

US

(Screening)

93.0% (318/342)

(90.3–95.7%)

7.0% (24/342)

(4.3–9.7%)

0.056

 

International

(Screening)

88.2% (179/203)

(83.7–92.6%)

11.8% (24/203)

(7.4–16.3%)

 
 

US

(Fractionation)

91.4% (213/233)

(87.8–95.0%)

8.6% (20/233)

(5.0–12.2%)

0.0010

 

International

(Fractionation)

79.0% (94/119)

(71.7–86.3%)

21.0% (25/119)

(13.7–28.3%)

 
  1. aProportion of correct abnormal analyte identified (analytic sensitivity).
  2. bProportion of incorrect abnormal analyte identified, or no abnormal analyte identified.
  3. cComparison of analytic sensitivity between US and international participants.